Publications found:
677
Sort by:
Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Erlotinib, Afatinib, Gefitinib, Osimertinib, Dacomitinib), By Distribution Channel (Online, Offline),By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market is projected to increase from USD 214.58 Million in 2025 to USD 326.38 Million by 2031, expanding at a CAGR of 7.24%. This...
January 2026
186 pages
PD-1 Resistant Head and Neck Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Cytotoxic Agents, EGFR Inhibitors, PD-1 Inhibitors, Pipeline Drugs), By End User (Hospitals, Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global PD-1 Resistant Head and Neck Cancer Market is projected to expand from USD 1.31 Billion in 2025 to USD 2.25 Billion by 2031, registering a CAGR of 9.43%. Therapies in this sector involve se...
January 2026
180 pages
Oral Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Type (Squamous Cell Carcinoma, Verrucous Carcinoma, Minor Salivary Gland Carcinomas, Lymphomas, others), By Treatment (Targeted Therapy, Chemotherapy, Immunotherapy), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Oral Cancer Treatment Market is projected to expand from USD 2.38 Billion in 2025 to USD 3.22 Billion by 2031, reflecting a compound annual growth rate of 5.17%. This sector encompasses a v...
January 2026
182 pages
Glioma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease (Astrocytoma, Oligoastrocytoma, Oligodendroglioma), By Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Others), By Grade (Low Grade, High Grade), By End user (Hospital & Clinics, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Glioma Treatment Market is projected to expand from a valuation of USD 9.34 Billion in 2025 to USD 14.78 Billion by 2031, reflecting a CAGR of 7.95%. This sector encompasses therapeutic int...
January 2026
181 pages
Image-Guided Radiation Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (4D RT, LINAC, MRI-guided radiotherapy, Portal CT Imaging), By Procedure (IMRT, Stereotactic, Particle), By Application (Neck, Prostate, Breast cancer), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Image-Guided Radiation Therapy Market is projected to expand from USD 2.02 Billion in 2025 to USD 2.78 Billion by 2031, registering a compound annual growth rate of 5.45%. This advanced tre...
January 2026
181 pages
Oncolytic Virotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Virus Type (Genetically Engineered Oncolytic Virus, Oncolytic Wild Type Virus), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, Pancreatic Cancer, Others), By End User (Hospitals & Clinics, Cancer Research Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Oncolytic Virotherapy Market is projected to expand from USD 49.73 Million in 2025 to USD 153.31 Million by 2031, registering a CAGR of 20.64%. This specialized field of cancer treatment ut...
January 2026
180 pages
Particle Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Proton therapy, Heavy-ion therapy), By System (Multi-room systems, Single-room systems), By Application (Treatment application, Research application), By Cancer-type (Pediatric Cancer, Lung Cancer, Breast cancer, Other cancers), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Particle Therapy Market is projected to expand from USD 999.21 Million in 2025 to USD 1362.93 Million by 2031, reflecting a compound annual growth rate of 5.31%. This specialized form of ex...
January 2026
185 pages
Skin Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Melanoma, Non-melanoma), By Treatment (Chemotherapy, Immunotherapy, Targeted Therapy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Skin Cancer Therapeutics Market is projected to expand from USD 6.89 Billion in 2025 to USD 10.51 Billion by 2031, reflecting a compound annual growth rate of 7.29%. This market encompasses...
January 2026
180 pages
Hyperthermia Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device Type (Microwave Hyperthermia Device, Ultrasound Hyperthermia Device, Infrared Hyperthermia Device, Short-wave Hyperthermia Device), By Application (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, Other Cancers), By End User (Hospitals & Clinics, Specialty Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hyperthermia Cancer Treatment Market is projected to expand from USD 201.25 Million in 2025 to USD 284.19 Million by 2031, registering a CAGR of 5.92%. Hyperthermia therapy involves raising...
January 2026
185 pages
Acute Lymphocytic Leukemia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Chemotherapy, Hyper-CVAD, CALGB 8811 regimen, Linker regimen, Nucleoside Metabolic Inhibitors, Oncaspar, Targeted therapy, Radiation Therapy, Stem cell transplantation), By Type (Philadelphia chromosome, Precursor B-cell ALL, T-cell ALL), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Acute Lymphocytic Leukemia Therapeutics Market is projected to expand from USD 4.21 Billion in 2025 to USD 5.99 Billion by 2031, reflecting a compound annual growth rate of 6.05%. This mark...
January 2026
182 pages
Invasive Ductal Carcinoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy, Immunotherapy), By Type (Hormone Receptor, HER2+), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Invasive Ductal Carcinoma Treatment Market will grow from USD 8.67 Billion in 2025 to USD 13.93 Billion by 2031 at a 8.22% CAGR. The Global Invasive Ductal Carcinoma Treatment Market involv...
January 2026
180 pages
NUT Midline Carcinoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Others), By Route Of Administration (Oral, Intravenous (IV), Other), By End-Use (Hospitals, Specialty Clinics, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global NUT Midline Carcinoma Treatment Market is projected to expand from USD 20.11 Billion in 2025 to USD 33.65 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 8.96%. This sec...
January 2026
180 pages
Epithelioma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Basal Cell Epithelioma, Squamous Cell Epithelioma, Other Epitheliomas), By Drug Class (Hedgehog Pathway Inhibitors, Immune Checkpoint Inhibitors, Chemotherapeutic Agents, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Epithelioma Treatment Market is projected to expand from a valuation of USD 5.22 Billion in 2025 to USD 8.75 Billion by 2031, progressing at a CAGR of 8.99%. This market centers on therapeu...
January 2026
185 pages
Robotic Radiotherapy Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Radiotherapy Systems, Software, 3D Cameras (Surface Guided), Others), By Technology (Linear Accelerators, Conventional Linear Accelerators, MRI - Linear Accelerators, Stereotactic Radiation Therapy Systems, Cyberknife, Gamma Knife, Particle Therapy, Proton Beam Therapy, Heavy Ion beam Therapy), By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer, Other), By End User (Hospitals, Independent Radiotherapy Centers), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Robotic Radiotherapy Market is projected to expand from USD 2.04 Billion in 2025 to USD 3.82 Billion by 2031, registering a CAGR of 11.02%. This sector involves medical systems that use rob...
January 2026
180 pages
Follicular Thyroid Cancer Drug Sales Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Papillary Carcinoma, Follicular Carcinoma, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Follicular Thyroid Cancer Drug Sales Market is projected to expand from USD 0.76 Billion in 2025 to USD 1.07 Billion by 2031, registering a CAGR of 5.81%. This market sector primarily consi...
January 2026
180 pages
Small Cell Lung Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (Immunotherapy, Targeted Therapy, Chemotherapy), By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate side, Pembrolizumab), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Small Cell Lung Cancer Therapeutics Market is projected to expand significantly, rising from USD 6.91 Billion in 2025 to USD 12.75 Billion by 2031, reflecting a compound annual growth rate...
January 2026
180 pages
Docetaxel Trihydrate API Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Purity ? 99%, Purity < 99%), By Application (Oncology, Research and Development, Others), By End-User (Pharmaceutical Companies, Research Institutes, Contract Manufacturing Organizations), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Docetaxel Trihydrate API Market is projected to expand from USD 1.45 Billion in 2025 to USD 2.11 Billion by 2031, registering a CAGR of 6.45%. This active pharmaceutical ingredient is a tax...
January 2026
180 pages
Mantle Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis (Laboratory exams, Imaging Tests, Bone marrow Biopsy, Others), By Treatment (Diagnosis {Imaging Tests, Surgical Examination, Others}, Therapy{Chemotherapy, Targeted therapy, Immunotherapy, Stem Cell Transplantation, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Mantle Cell Lymphoma Market is projected to expand from USD 2.71 Billion in 2025 to USD 4.28 Billion by 2031, registering a CAGR of 7.91%. This rare and aggressive B-cell malignancy, marked...
January 2026
181 pages
Head and Neck Cancer Therapeutics Market- Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type (Diagnostic Methods, Treatment Type), By Diagnostic Methods (Biopsy, Imaging, Endoscopy, Others), By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By Disease Indication (Lip and Oral Cavity Cancer, Laryngeal Cancer, Oropharyngeal Cancer, Salivary Gland Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer), By Route of Administration (Injectable, Oral), By Therapeutic Class (PD Inhibitors, EGFR Inhibitors, Microtubule Inhibitors), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Head and Neck Cancer Therapeutics Market is projected to expand significantly, rising from USD 2.38 Billion in 2025 to USD 4.91 Billion by 2031, reflecting a compound annual growth rate of...
January 2026
182 pages
Leukemia Therapeutics Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia, Others), By Gender (Male, Female), By Age Groups (0-15, 15-30, 30-50, 50+), By Diagnosis (Blood Test, Biopsy, Physical Exam, Imaging), By Treatment (Chemotherapy, Stem Cell Transplantation, Immunotherapy, Targeted Therapy, Others), By Drugs (Tyrosine Kinase Inhibitors, Antimetabolites, Hormones (Corticosteroids), Monoclonal Antibodies, Others), By Route of Administration (Oral, Parenteral), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Leukemia Therapeutics Market is projected to expand from USD 16.51 Billion in 2025 to USD 26.95 Billion by 2031, achieving a CAGR of 8.51%. These therapeutics comprise a wide range of medic...
January 2026
182 pages
Liver Cancer Therapeutics Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Liver Metastasis, Hepatoblastoma, Angiosarcoma), By Therapy (Targeted Therapy, Radiation and Chemotherapy Therapy, Immunotherapy, Others), By Equipment (Computed Radiography, MRI, Sonography, Others), By Age (0-18, 18-35, 35-50, 50+), By Factors (Non-Alcoholic Fatty Liver Disease, Cirrhosis, Excessive Liver Consumption, Others), By Route of Administration (Oral, Intra-Venous, Others ), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Liver Cancer Therapeutics Market is projected to expand from USD 4.11 Billion in 2025 to USD 6.94 Billion by 2031, reflecting a CAGR of 9.12%. This market encompasses pharmacological interv...
January 2026
180 pages
Locally Advanced Pancreatic Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Surgery), By Route of administration (Oral, Injectables, Others), By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Locally Advanced Pancreatic Cancer Market is projected to expand from USD 938.73 Million in 2025 to USD 1680.33 Million by 2031, registering a compound annual growth rate of 10.19%. Locally...
January 2026
180 pages
Photoimmunotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Area (Head & Neck Cancer, Metastatic Melanoma, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Biotechnology & Pharmaceutical Companies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Photoimmunotherapy Market is projected to expand from USD 1.99 Billion in 2025 to USD 3.65 Billion by 2031, reflecting a compound annual growth rate of 10.64%. This targeted oncological app...
January 2026
182 pages
Multiple Myeloma Market - Forecast from 2026 to 2031
US$ 3,950.00
Multiple Myeloma Market is projected to expand at a 6.22% CAGR, reaching USD 37.67 billion in 2031 from USD 26.231 billion in 2025. The multiple myeloma market represents a dynamic and rapidly evolvin...
January 2026
150 pages
Glioblastoma Multiforme Treatment Market Size, Share & Trends Analysis Report By Treatment (Surgery, Radiation Therapy, Chemotherapy), By End Use (Hospitals, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global glioblastoma multiforme treatment market size was estimated at USD 4.04 billion in 2025 and is projected to reach USD 7.87 billion by 2033, growing at a CAGR of 8.69% from 2026 to 2033. The...
January 2026
150 pages
Immunotherapy Drugs Market Size, Share & Trends Analysis Report By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccine), By Indication (Cancer, Infectious Diseases, Autoimmune Diseases), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global immunotherapy drugs market size was estimated at USD 285.73 billion in 2025 and is expected to reach USD 675.98 billion by 2033, growing at a CAGR of 11.41% from 2026 to 2033. This market i...
January 2026
100 pages
The 2027-2032 World Outlook for Liver Cancer Drugs
US$ 1,195.00
This study covers the world outlook for liver cancer drugs across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for liver cancer drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Multiple Myeloma Therapeutics
US$ 1,195.00
This econometric study covers the world outlook for multiple myeloma therapeutics across more than 200 countries. For each year reported, ... worldwide latent demand, or the P.I.E., for multiple myeloma therapeutics. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each ...
January 2026
288 pages
The 2027-2032 World Outlook for Non-Small Cell Lung Cancer Therapeutics
US$ 1,195.00
This econometric study covers the world outlook for non-small cell lung cancer therapeutics across more than 200 countries. For each year reported, ... worldwide latent demand, or the P.I.E., for non-small cell lung cancer therapeutics. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each ...
January 2026
291 pages
The 2027-2032 World Outlook for Pancreatic Cancer Drugs
US$ 1,195.00
This study covers the world outlook for pancreatic cancer drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for pancreatic cancer drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Prostate Cancer Therapeutics
US$ 1,195.00
... study covers the world outlook for prostate cancer therapeutics across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... P.I.E., for prostate cancer therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
289 pages
Global Intravesical Bacillus Calmette Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... display the global Intravesical Bacillus Calmette market. Chapter 1, to describe Intravesical Bacillus Calmette Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Intravesical Bacillus Calmette, with ...
January 2026
77 pages
The 2027-2032 World Outlook for Angiogenesis Inhibitors and Stimulators
US$ 1,195.00
This study covers the world outlook for angiogenesis inhibitors and stimulators across more than 190 countries. For each year ... demand, or the P.I.E., for angiogenesis inhibitors and stimulators. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...
January 2026
290 pages
